Sharon Laboratories Reaches Agreement to Acquire B&C Cosmetic Ingredients and Research & Innovation Units

  • Home
  • News & Events
  • Sharon Laboratories Reaches Agreement to Acquire B&C Cosmetic Ingredients and Research & Innovation Units

Sharon Laboratories Reaches Agreement to Acquire B&C Cosmetic Ingredients and Research & Innovation Units

Strategic acquisition will expand Sharon Laboratories cosmetic ingredients portfolio and enhance the company’s focus on green, natural and sustainable technology

Ashdod, Israel – 23 March 2022 – Sharon Laboratories, Ltd. (Ashdod, Israel), a leading global innovator and manufacturer of preservative solutions for cosmetics and personal care markets, announced today that it has signed a definitive agreement to acquire the cosmetic ingredients unit of Gorla Minore, Italy-based B&C S.p.A., as well as the company’s research and innovation unit, CR&D. This is the second acquisition by Sharon Laboratories this month, having announced an agreement to acquire Res Pharma Industriale on March 1.

Founded in 2007, B&C produces a unique line of bio-active ingredients that bring added value to cosmetic brands and consumers, with a strong focus on skin benefits and wellness. The company develops natural and sustainable ingredients, offering excipients and green phytoactive substances, such as delivery systems, emulsifiers and emollients. CR&D is a subsidiary of B&C, and it serves as the company’s dedicated research and development arm. It is responsible for the organization’s innovation and technology development.

“The unique product offering of B&C’s cosmetic division will expand Sharon’s portfolio, as well as the value we bring to our strong, global customer base, adding more natural-based ingredients to our offering,” said Naama Eylon, General Manager of Sharon Laboratories. “We are excited and looking forward to bringing the cosmetic division of B&C and CR&D into Sharon Laboratories. I believe the team’s customer-centric approach, and the benefit it brings to the product creation and development process is completely aligned with Sharon. Our new organization structure will only continue to promote this link between product innovation and market needs.”

The closing for the acquisition is subject to the completion of certain conditions and is expected to be completed during the second quarter of 2022. Following completion of the acquisition, B&C’s cosmetic unit and its CR&D research subsidiary will be integrated into Sharon Laboratories’ business.

Reflecting on the history of the company, and the Sharon Laboratories acquisition, Roberta Donadelli, founder of CR&D, said: “I am excited for B&C cosmetic and CR&D to enter a new beginning with Sharon Laboratories. We have always focused on the long-term goals and success of the business. Our team’s passion for cosmetic science, combined with its entrepreneurial spirit, has strongly motivated us to put the company’s sustainable growth first. As founder and stakeholders of the formers, I found a great link to Sharon, as I recognize this core value within Sharon’s vision, and I am looking forward to this step as an opportunity to drive further positive changes in the cosmetic industry.”

Gabriele Dotti, shareholder, is adding “I am extremely positive and I take pride in the goal we have accomplished recently. This operation aims at accelerating the internationalization process, thus achieving long-term growth. I am confident that the B&C Cosmetic group will live up to this new challenge”.


22 copy 1

About Sharon Laboratories

Headquartered in Ashdod, Israel, Sharon Laboratories offers a wide range of innovative and patented preservative solutions for personal care products, following a focused, scientific approach to addressing the industry’s most challenging preservation needs.

Established in 1977 by Dr. Danny Sommerfeld, the company employs more than 100 people worldwide, focusing on scientific research, development and marketing of advanced preservative solutions. Sharon Laboratories has a global presence. In 2019 it established its first European operation in Italy and expanded to North America when Sharon Labs USA started operating in 2021. The company markets a broad line of green preservative solutions under its SharoSENSE™, Sharomix™, Sharon™ Biomix, SharoSUN™, Sharowipes™ brand names.

Sharon Laboratories is owned by Tene Investment Funds (Tel Aviv), an Israeli private equity growth fund focused on the industrial and technology sectors, as the majority holding, as well as Mr. Assaf Burstein, Sharon’s Chairman.

About B&C

Founded in 2007, B&C S.p.A. is a specialty producer and supplier to the cosmetic and food segment. Located in Gorla Minore, near Milan. The cosmetic ingredients unit, led by the cosmetic research department CR&D, and in collaboration with Italian universities, specializes in natural active ingredients and innovative hyaluronic acid-based systems, as well as green emulsifiers, surfactants, and emollients. The food unit specializes in texturizers, emulsifiers and stabilizers for ice creams, dairy drinks, desserts and more.



Fineurop Soditic acted as exclusive financial advisor to Sharon Laboratories with a team composed of Gilberto Baj Macario (Senior Partner) and Pietro Maria Rinaldi (Senior Analyst).

Alessandro Giuliani and Nicola Zito of Gianni & Origoni represented Sharon as legal advisors.

Gatti Pavesi Bianchi Ludovici with Michele Aprile (Partner) and Daniele Canola (associate) acted as tax advisor to B&C shareholders and Roberta Donadelli.

Need more information?